4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-003854
Chief Executive Officer gave up 190,287 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-01-15 | Shares withheld for taxes | −190,287 | $1.05 | $199,801 | 2,244,713 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…